Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Share-based Compensation: 2017-2024

Historic Share-based Compensation for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $2.1 million.

  • DiaMedica Therapeutics' Share-based Compensation rose 516.92% to $401,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.2 million, marking a year-over-year increase of 87.74%. This contributed to the annual value of $2.1 million for FY2024, which is 23.89% up from last year.
  • As of FY2024, DiaMedica Therapeutics' Share-based Compensation stood at $2.1 million, which was up 23.89% from $1.7 million recorded in FY2023.
  • Over the past 5 years, DiaMedica Therapeutics' Share-based Compensation peaked at $2.1 million during FY2024, and registered a low of $1.5 million during FY2022.
  • Moreover, its 3-year median value for Share-based Compensation was $1.7 million (2023), whereas its average is $1.8 million.
  • As far as peak fluctuations go, DiaMedica Therapeutics' Share-based Compensation skyrocketed by 58.33% in 2020, and later declined by 15.46% in 2021.
  • DiaMedica Therapeutics' Share-based Compensation (Yearly) stood at $1.8 million in 2020, then declined by 15.46% to $1.6 million in 2021, then declined by 3.59% to $1.5 million in 2022, then grew by 12.05% to $1.7 million in 2023, then climbed by 23.89% to $2.1 million in 2024.